Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trypanosoma brucei brucei | 14 | 2023 | 19 | 4.140 |
Why?
|
| Aquaglyceroporins | 8 | 2019 | 8 | 2.370 |
Why?
|
| Trypanosomiasis, African | 2 | 2023 | 3 | 0.960 |
Why?
|
| Oocytes | 8 | 2019 | 281 | 0.800 |
Why?
|
| Antimony | 3 | 2013 | 14 | 0.780 |
Why?
|
| Bufo marinus | 1 | 2019 | 3 | 0.590 |
Why?
|
| Dihydroxyacetone | 3 | 2007 | 3 | 0.590 |
Why?
|
| Glycerol | 5 | 2018 | 78 | 0.580 |
Why?
|
| Pyruvaldehyde | 1 | 2018 | 3 | 0.580 |
Why?
|
| Microglia | 4 | 2023 | 143 | 0.570 |
Why?
|
| Acetates | 1 | 2018 | 78 | 0.550 |
Why?
|
| Lactic Acid | 1 | 2018 | 148 | 0.540 |
Why?
|
| Trypanocidal Agents | 2 | 2007 | 33 | 0.520 |
Why?
|
| Boric Acids | 1 | 2017 | 2 | 0.510 |
Why?
|
| Recombinant Proteins | 2 | 2019 | 1318 | 0.480 |
Why?
|
| Leishmania major | 3 | 2010 | 27 | 0.440 |
Why?
|
| Gene Expression | 1 | 2019 | 1487 | 0.420 |
Why?
|
| Biological Transport | 7 | 2018 | 330 | 0.410 |
Why?
|
| Arsenites | 1 | 2013 | 18 | 0.400 |
Why?
|
| Crotalid Venoms | 3 | 2018 | 9 | 0.390 |
Why?
|
| Aquaporin 1 | 3 | 2011 | 5 | 0.370 |
Why?
|
| Autophagy | 4 | 2016 | 423 | 0.360 |
Why?
|
| Animals | 26 | 2026 | 33862 | 0.310 |
Why?
|
| Drug Resistance | 2 | 2010 | 239 | 0.290 |
Why?
|
| Leishmania | 2 | 2025 | 34 | 0.270 |
Why?
|
| Bothrops | 2 | 2018 | 2 | 0.260 |
Why?
|
| Disintegrins | 2 | 2016 | 11 | 0.250 |
Why?
|
| Soil Microbiology | 1 | 2026 | 19 | 0.240 |
Why?
|
| Toxocara | 1 | 2026 | 16 | 0.240 |
Why?
|
| Ascomycota | 1 | 2026 | 28 | 0.240 |
Why?
|
| Taeniasis | 1 | 2005 | 3 | 0.230 |
Why?
|
| Cysticercosis | 1 | 2005 | 21 | 0.230 |
Why?
|
| Helminths | 1 | 2026 | 52 | 0.230 |
Why?
|
| Soil | 1 | 2026 | 75 | 0.230 |
Why?
|
| Xenopus laevis | 4 | 2017 | 112 | 0.220 |
Why?
|
| Glyburide | 1 | 2005 | 21 | 0.220 |
Why?
|
| Leishmaniasis | 1 | 2025 | 41 | 0.220 |
Why?
|
| Helminthiasis | 1 | 2026 | 83 | 0.220 |
Why?
|
| Cell Cycle | 1 | 2007 | 599 | 0.220 |
Why?
|
| Aquaporins | 1 | 2004 | 11 | 0.220 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2017 | 411 | 0.210 |
Why?
|
| Permeability | 3 | 2017 | 119 | 0.210 |
Why?
|
| Dengue | 1 | 2025 | 122 | 0.210 |
Why?
|
| Central Nervous System | 2 | 2023 | 276 | 0.200 |
Why?
|
| Adaptive Immunity | 1 | 2024 | 102 | 0.200 |
Why?
|
| Flow Cytometry | 3 | 2019 | 771 | 0.190 |
Why?
|
| Models, Animal | 1 | 2024 | 451 | 0.180 |
Why?
|
| Adjuvants, Immunologic | 1 | 2024 | 391 | 0.180 |
Why?
|
| Amino Acid Sequence | 6 | 2016 | 2406 | 0.180 |
Why?
|
| Zebrafish | 1 | 2024 | 419 | 0.170 |
Why?
|
| Immunity, Innate | 1 | 2024 | 408 | 0.170 |
Why?
|
| Xenopus | 4 | 2016 | 103 | 0.170 |
Why?
|
| Chagas Disease | 1 | 2025 | 323 | 0.170 |
Why?
|
| Phagocytosis | 2 | 2019 | 188 | 0.170 |
Why?
|
| Inpatients | 1 | 2005 | 559 | 0.170 |
Why?
|
| Brain | 3 | 2023 | 3164 | 0.160 |
Why?
|
| Glucose | 1 | 2005 | 853 | 0.160 |
Why?
|
| Vaccines | 1 | 2024 | 384 | 0.150 |
Why?
|
| Pyruvic Acid | 1 | 2018 | 35 | 0.140 |
Why?
|
| Host-Parasite Interactions | 1 | 2019 | 72 | 0.140 |
Why?
|
| Stereoisomerism | 1 | 2018 | 109 | 0.140 |
Why?
|
| Protozoan Proteins | 2 | 2011 | 127 | 0.140 |
Why?
|
| Glycolysis | 1 | 2018 | 175 | 0.130 |
Why?
|
| Mental Disorders | 1 | 2005 | 899 | 0.130 |
Why?
|
| Excitatory Amino Acid Transporter 1 | 1 | 2016 | 3 | 0.130 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2016 | 14 | 0.130 |
Why?
|
| Molecular Sequence Data | 4 | 2016 | 3487 | 0.130 |
Why?
|
| Cell Death | 2 | 2007 | 233 | 0.130 |
Why?
|
| Metalloproteases | 1 | 2016 | 14 | 0.120 |
Why?
|
| Agkistrodon | 1 | 2016 | 3 | 0.120 |
Why?
|
| Kv1.5 Potassium Channel | 1 | 2016 | 8 | 0.120 |
Why?
|
| Venoms | 1 | 2016 | 17 | 0.120 |
Why?
|
| Prostaglandin D2 | 2 | 2006 | 4 | 0.120 |
Why?
|
| Brain Diseases | 1 | 2018 | 298 | 0.120 |
Why?
|
| Biological Assay | 1 | 2016 | 106 | 0.110 |
Why?
|
| Substrate Specificity | 2 | 2005 | 285 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 430 | 0.100 |
Why?
|
| Kinetics | 2 | 2007 | 1087 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2016 | 832 | 0.100 |
Why?
|
| Mice | 5 | 2023 | 18243 | 0.100 |
Why?
|
| Glutamic Acid | 2 | 2016 | 194 | 0.100 |
Why?
|
| Venezuela | 2 | 2018 | 14 | 0.090 |
Why?
|
| Amino Acid Substitution | 2 | 2010 | 404 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 2 | 2010 | 716 | 0.080 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2007 | 117 | 0.080 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2007 | 131 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2016 | 623 | 0.080 |
Why?
|
| Alanine | 1 | 2010 | 160 | 0.080 |
Why?
|
| Aquaporin 3 | 2 | 2011 | 2 | 0.080 |
Why?
|
| Aquaporin 2 | 2 | 2011 | 5 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 2 | 2007 | 308 | 0.080 |
Why?
|
| Transcriptome | 1 | 2016 | 1123 | 0.070 |
Why?
|
| Apoptosis | 2 | 2006 | 1832 | 0.070 |
Why?
|
| Osmosis | 2 | 2007 | 17 | 0.070 |
Why?
|
| Water | 2 | 2010 | 185 | 0.070 |
Why?
|
| Eukaryotic Cells | 1 | 2007 | 29 | 0.070 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2007 | 84 | 0.070 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2007 | 46 | 0.070 |
Why?
|
| Reactive Oxygen Species | 2 | 2007 | 521 | 0.070 |
Why?
|
| Chemotaxis | 1 | 2007 | 62 | 0.070 |
Why?
|
| Cell Size | 1 | 2007 | 81 | 0.060 |
Why?
|
| Africa | 1 | 2007 | 140 | 0.060 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2007 | 73 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 226 | 0.060 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2007 | 144 | 0.060 |
Why?
|
| Toxoplasma | 1 | 2006 | 18 | 0.060 |
Why?
|
| Guidelines as Topic | 1 | 2007 | 199 | 0.060 |
Why?
|
| Ammonia | 1 | 2006 | 68 | 0.060 |
Why?
|
| Plasmodium falciparum | 1 | 2006 | 80 | 0.060 |
Why?
|
| DNA, Fungal | 1 | 2026 | 77 | 0.060 |
Why?
|
| Latin America | 1 | 2026 | 107 | 0.060 |
Why?
|
| Ecuador | 1 | 2025 | 15 | 0.060 |
Why?
|
| Glucose-6-Phosphate Isomerase | 1 | 2005 | 1 | 0.060 |
Why?
|
| Glutamate Dehydrogenase | 1 | 2005 | 3 | 0.060 |
Why?
|
| Cytochalasin B | 1 | 2005 | 8 | 0.060 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2005 | 21 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2006 | 401 | 0.060 |
Why?
|
| Hexokinase | 1 | 2005 | 24 | 0.060 |
Why?
|
| Antibodies, Helminth | 1 | 2005 | 131 | 0.060 |
Why?
|
| Seroepidemiologic Studies | 1 | 2025 | 165 | 0.060 |
Why?
|
| Cell Survival | 1 | 2007 | 836 | 0.060 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2005 | 43 | 0.060 |
Why?
|
| Antibodies, Protozoan | 1 | 2025 | 101 | 0.060 |
Why?
|
| Mutation | 3 | 2008 | 6119 | 0.050 |
Why?
|
| Alanine Transaminase | 1 | 2005 | 157 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2004 | 234 | 0.050 |
Why?
|
| Dengue Virus | 1 | 2025 | 134 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 192 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2016 | 276 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 1610 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2026 | 528 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 780 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2016 | 301 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2025 | 792 | 0.050 |
Why?
|
| Trypanosoma cruzi | 1 | 2025 | 261 | 0.050 |
Why?
|
| Phylogeny | 1 | 2004 | 688 | 0.050 |
Why?
|
| Feces | 1 | 2005 | 721 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2004 | 899 | 0.040 |
Why?
|
| Humans | 9 | 2026 | 130483 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 1374 | 0.040 |
Why?
|
| Healthy Aging | 1 | 2019 | 13 | 0.040 |
Why?
|
| Oxidative Stress | 2 | 2018 | 796 | 0.040 |
Why?
|
| Mutant Proteins | 2 | 2010 | 112 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 3712 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2018 | 66 | 0.040 |
Why?
|
| Prevalence | 1 | 2025 | 2699 | 0.030 |
Why?
|
| Lethal Dose 50 | 1 | 2018 | 17 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2018 | 232 | 0.030 |
Why?
|
| Caseins | 1 | 2018 | 65 | 0.030 |
Why?
|
| Fibrinolysis | 1 | 2018 | 42 | 0.030 |
Why?
|
| Geography | 1 | 2018 | 115 | 0.030 |
Why?
|
| Fibrinogen | 1 | 2018 | 167 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2019 | 246 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 2018 | 134 | 0.030 |
Why?
|
| Proteolysis | 1 | 2018 | 197 | 0.030 |
Why?
|
| Gelatinases | 1 | 2016 | 15 | 0.030 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2016 | 37 | 0.030 |
Why?
|
| Cations | 1 | 2016 | 38 | 0.030 |
Why?
|
| RNA, Complementary | 1 | 2016 | 5 | 0.030 |
Why?
|
| Ouabain | 1 | 2016 | 17 | 0.030 |
Why?
|
| Expressed Sequence Tags | 1 | 2016 | 80 | 0.030 |
Why?
|
| Nedd4 Ubiquitin Protein Ligases | 1 | 2016 | 10 | 0.030 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2016 | 28 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2016 | 254 | 0.030 |
Why?
|
| Xenopus Proteins | 1 | 2016 | 55 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2018 | 466 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2016 | 198 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2016 | 148 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2016 | 273 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2016 | 319 | 0.030 |
Why?
|
| Rabbits | 1 | 2016 | 573 | 0.030 |
Why?
|
| Multigene Family | 1 | 2016 | 290 | 0.030 |
Why?
|
| Middle Aged | 2 | 2025 | 28438 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2007 | 262 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2016 | 586 | 0.030 |
Why?
|
| Phenotype | 1 | 2004 | 4479 | 0.030 |
Why?
|
| Fibrinolytic Agents | 1 | 2016 | 191 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2016 | 2469 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2016 | 450 | 0.030 |
Why?
|
| Adult | 2 | 2025 | 31179 | 0.030 |
Why?
|
| Macrophages | 1 | 2018 | 657 | 0.030 |
Why?
|
| Time Factors | 1 | 2004 | 6200 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2018 | 491 | 0.030 |
Why?
|
| Calcium | 1 | 2019 | 1028 | 0.030 |
Why?
|
| Cognition | 1 | 2019 | 811 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2016 | 503 | 0.020 |
Why?
|
| Male | 3 | 2025 | 64488 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2016 | 360 | 0.020 |
Why?
|
| Action Potentials | 1 | 2016 | 470 | 0.020 |
Why?
|
| Skin | 1 | 2016 | 540 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2016 | 673 | 0.020 |
Why?
|
| Female | 3 | 2025 | 70388 | 0.020 |
Why?
|
| Pyruvates | 1 | 2011 | 18 | 0.020 |
Why?
|
| Aging | 1 | 2019 | 1244 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2011 | 97 | 0.020 |
Why?
|
| Young Adult | 1 | 2025 | 10010 | 0.020 |
Why?
|
| Metalloids | 1 | 2010 | 1 | 0.020 |
Why?
|
| Mercaptoethanol | 1 | 2010 | 2 | 0.020 |
Why?
|
| Reducing Agents | 1 | 2010 | 3 | 0.020 |
Why?
|
| Risk Factors | 1 | 2005 | 10953 | 0.020 |
Why?
|
| Water-Electrolyte Balance | 1 | 2011 | 80 | 0.020 |
Why?
|
| Computational Biology | 1 | 2016 | 862 | 0.020 |
Why?
|
| Organic Chemicals | 1 | 2010 | 58 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 903 | 0.020 |
Why?
|
| Mercury | 1 | 2010 | 31 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 382 | 0.020 |
Why?
|
| Infant | 1 | 2025 | 13234 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2025 | 14945 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 1817 | 0.020 |
Why?
|
| Autophagy-Related Protein 8 Family | 1 | 2007 | 3 | 0.020 |
Why?
|
| Phagosomes | 1 | 2007 | 37 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 562 | 0.020 |
Why?
|
| Life Cycle Stages | 1 | 2007 | 25 | 0.020 |
Why?
|
| Plants | 1 | 2007 | 50 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2007 | 66 | 0.020 |
Why?
|
| Leishmania donovani | 1 | 2007 | 26 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2010 | 1060 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2025 | 17550 | 0.020 |
Why?
|
| Aged | 1 | 2025 | 20918 | 0.020 |
Why?
|
| Adolescent | 1 | 2025 | 20737 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 2006 | 89 | 0.020 |
Why?
|
| Methylamines | 1 | 2006 | 21 | 0.020 |
Why?
|
| Protein Transport | 1 | 2007 | 370 | 0.020 |
Why?
|
| Cell Line | 1 | 2011 | 2566 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2007 | 253 | 0.020 |
Why?
|
| DNA, Protozoan | 1 | 2006 | 26 | 0.010 |
Why?
|
| Phosphatidylserines | 1 | 2006 | 45 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2006 | 309 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2007 | 361 | 0.010 |
Why?
|
| Cycloheximide | 1 | 2005 | 42 | 0.010 |
Why?
|
| Caspase Inhibitors | 1 | 2005 | 30 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2005 | 26 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 119 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2006 | 292 | 0.010 |
Why?
|
| Arginine | 1 | 2007 | 337 | 0.010 |
Why?
|
| Child | 1 | 2025 | 26101 | 0.010 |
Why?
|
| Models, Biological | 1 | 2007 | 1386 | 0.010 |
Why?
|
| Mitochondria | 1 | 2006 | 775 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2006 | 1597 | 0.010 |
Why?
|
UZCATEGUI ARAUJO's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(239)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(17)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_